AcneFeatured PodcastPodcast Highlights

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

By March 2, 2021April 1st, 2022No Comments

JDD Multimedia

Love15

JDD Podcast

Listen Now

Play Video

How to Listen

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman

 

Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer to a chunky peanut butter sandwich (just go with me on this), so too have tetracycline antibiotics been married to the management of Acne Vulgaris. And just as that delicious combo comes at a fattening cost, the overuse and abuse of antibiotics has an impressive and significant impact both on the risk for antimicrobial resistance and gut/cutaneous dysbiosis.

To get to the piloseabeous unit of the matter, JDD Podcast host Dr. Adam Friedman picks the brains of AAA experts Dr. Emmy Graber and Dr. Mahmoud Ghannoum to provide a true bench to bedside review of the issues at hand. Pop in to learn how to interpret minimum inhibitory concentrations (MIC), understand newly identified information on dysbiosis (including impaired microbiota), and appreciate the implications of indiscriminate use of broad-spectrum antibiotics in acne therapy including the clinical consequence of antibiotic resistance and benefits of narrow-spectrum agents.

Listen Now
Learning Objectives
Upon completion of this podcast participants should be able to:
  • Describe the differences between antibiotic types and their use in acne therapy
  • Discuss interpretation and measurement of MIC, resistance and dysbiosis
  • Summarize the clinical implications of antibiotic resistance
  • Summarize the clinical implications of dysbiosis
This enduring activity is supported by an independent medical education grant provided by Almirall, LLC.
Disclosures
Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speakers’ Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
Mahmoud Ghannoum, PhD – Grant/Research: Almirall. Consultant: Almirall.
Emmy M. Graber, MD, MBA – Grant/Research: Ortho Dermatologics. Consultant: Almirall, Digital Diagnostics, Sebacia, SolGel. Speakers’ Bureau: Almirall

You May Also Like

AD Treatment – The Future Landscape

| Atopic Dermatitis, Featured Podcast, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Amy Paller, Jonathan Silverberg & Adam Friedman   Consider this final episode of the 5 part all you can handle Atopic Dermatitis series the…

Perspectives on Managing Moderate-to-Severe Atopic Dermatitis

| Atopic Dermatitis, Featured Podcast, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. April Armstrong, Lawrence Eichenfield & Adam Friedman   The Ps of Lichen Planus got nothing on this alliteration filled podcast that was purposefully positioned…

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

| Acne, Featured Podcast, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman   Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer…

Get More from the JDD Podcast

Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.

Discover the latest research, exclusive articles from leading dermatology experts,popular Podcast episodes, free CME activities, and more!

Subscribe
This error message is only visible to WordPress admins

Error: No feed found.

Please go to the Instagram Feed settings page to create a feed.

Tags:

Leave a Reply

Close Menu